H.i.g. capital completes the sale of biovectra

Miami--(business wire)-- #acquisition--h.i.g. capital sold its portfolio company, biovectra inc., to agilent technologies, inc. (nyse: a) for a purchase price of $925 million.
A Ratings Summary
A Quant Ranking